Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Lung Cancer Screening Market: By Cancer Type, and Small Cell Lung Cancer), By Diagnosis Type, By End-Users and Geography
Lung Cancer Screening Market size was valued at US$ 2,862.1 million in 2023 and is poised to grow at a significant CAGR of 6.5% from 2024-2030. A type of disease that occurs in the lungs is known as lung cancer. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the 2 main types of lung cancer and are treated differently. The non-small cell lung cancer segment is anticipated to grow at a significant CAGR over the forecast years owing to non-small cell lung cancer being the most common type of cancer accounting for approximately 85% of all lung cancers.
However, non-small cell Lung cancer metastasizes to another organ slower in compression to SCLC, and microscopically, SCLC is composed of much smaller cells. if untreated, SCLC can be fatal in a few weeks, in contrast to most cases of NSCLC. Moreover, as per the research, non-small cell lung cancer accounts for 85% of all lung cancer cases in the United States after the initial diagnosis. The prevalence of lung cancer cases worldwide, greater emphasis on technological developments in the production of medical devices, and rising spending on the expansion of healthcare infrastructure, particularly in developing economies, are the main drivers of the market.
Study Period
2024-2030Base Year
2023CAGR
6.5%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The lung cancer screening market is anticipated to grow in the forecasting period owing to surge in the incidence of the type of cancer due to increase smoking population, technology advancement in screening, and increasing in government support of early detection of cases. Moreover, other player is focusing on strategy and collaboration are also likely to boost the market growth in the near future. For instance, In September 2021Genentech and Roche are actively exploring the development of biomarker to test lung cancer and detection.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 2,862.1 million |
Market CAGR |
6.5% |
By Cancer Type |
|
By Diagnosis Type |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global lung cancer screening market size was valued at US$ 2,862.1 million in 2023 and is projected to grow at a significant CAGR of 6.5% from 2024-2030
PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmbH
Asia Pacific is the fastest-growing region for lung cancer screening market
1.Executive Summary |
2.Global Lung Cancer Screening Market Introduction |
2.1.Global Lung Cancer Screening Market - Taxonomy |
2.2.Global Lung Cancer Screening Market - Definitions |
2.2.1. By Cancer Type |
2.2.2. By Diagnosis Type |
2.2.3. By End User |
2.2.4. By Region |
3.Global Lung Cancer Screening Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Lung Cancer Screening Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Lung Cancer Screening Market By Cancer Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Non-Small Cell Lung Cancer (NSCLC) |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Small Cell Lung Cancer |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Lung Cancer Screening Market By Diagnosis Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Low Dose Spiral CT scan |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Chest X-Ray |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Lung Cancer Screening Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Hospital & Clinics |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Diagnostic Centers |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8.Global Lung Cancer Screening Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Cancer Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Non-Small Cell Lung Cancer (NSCLC) |
9.1.2.Small Cell Lung Cancer |
9.2. Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Low Dose Spiral CT scan |
9.2.2.Chest X-Ray |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospital & Clinics |
9.3.2.Diagnostic Centers |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Cancer Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Non-Small Cell Lung Cancer (NSCLC) |
10.1.2.Small Cell Lung Cancer |
10.2. Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Low Dose Spiral CT scan |
10.2.2.Chest X-Ray |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospital & Clinics |
10.3.2.Diagnostic Centers |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Cancer Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Non-Small Cell Lung Cancer (NSCLC) |
11.1.2.Small Cell Lung Cancer |
11.2. Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Low Dose Spiral CT scan |
11.2.2.Chest X-Ray |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospital & Clinics |
11.3.2.Diagnostic Centers |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Cancer Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Non-Small Cell Lung Cancer (NSCLC) |
12.1.2.Small Cell Lung Cancer |
12.2. Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Low Dose Spiral CT scan |
12.2.2.Chest X-Ray |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospital & Clinics |
12.3.2.Diagnostic Centers |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Lung Cancer Screening Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Cancer Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Non-Small Cell Lung Cancer (NSCLC) |
13.1.2.Small Cell Lung Cancer |
13.2. Diagnosis Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Low Dose Spiral CT scan |
13.2.2.Chest X-Ray |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospital & Clinics |
13.3.2.Diagnostic Centers |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.PenRad Technologies Inc. |
14.2.2.Koninklijke Philips N.V |
14.2.3.Volpara Health Limited |
14.2.4.Thynk Health |
14.2.5.Nuance Communications, Inc. |
14.2.6.Siemens Healthcare GmbH |
14.2.7.MyCareWare, Inc. |
14.2.8.MagView |
14.2.9.MeVis Medical Solutions AG |
14.2.10.Canon Medical Informatics, Inc. |
14.2.11.General Electric Company |
14.2.12.Epic Systems Corporation |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players